Leslie Galloway

U.S. News & World Report Nationally Ranked in Six Specialties UF Health Shands Children’s Hospital again ranks among the nation’s best, with three pediatric specialties recognized as the top programs…

Dr. Michael Haller recently joined the Diabetes Connections podcast to discuss two important areas of research: preventing type 1 diabetes and inhaled insulin for kids.

As both a UF Health Shands team member and the mother of a patient, Taylor Smith, RN, sees UF Health as more than a workplace — it’s part of her family’s story. Smith has served in the UF Health Shands E.R. since 2018 and became an ER coordinator…

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.

Three medical specialties at University of Florida Health Shands Children’s Hospital were rated the best in Florida and in the top 50 nationally in the U.S. News & World Report annual ranking of the nation’s pediatric hospitals released today. Three additional specialties also placed in the top 50 nationwide.

In Memoriam 1962 – 2025​ Mariny Coleman We are saddened to share the passing of Mariny Coleman, Assistant Team Coordinator for the UF Child Protection Team. For more than 15…

Jim and Marilyn Islam Fund for Pediatric Cancer Research will support rising star professorship…

Imagine if when a soon-to-be mother arrived at a hospital in labor, her health care team could predetermine what challenges she might encounter with breastfeeding and develop a game plan to address any lactation complications, before she even gave birth.

Saturday, October 25, 2025 from 8 – 11 a.m. Join us for the 4th annual Cancer Chomp, a day of community engagement, peer support and survivor recognition in acknowledgment of the unique challenges faced by brain tumor patients and their loved ones.

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to “wake up” the immune system against cancer.